EUVIMEDEUVIMED entdecken
Crossref

Acute Outcomes and Cardiac Functions in Severe COVID-19

Ümmü Taş, Sedat Taş

Muş Alparslan Üniversitesi Sağlık Bilimleri Dergisi · 2025

DOI: 10.71255/maunsbd.1685179 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Muş Alparslan Üniversitesi Sağlık Bilimleri Dergisi, 2025. Verfasst von Ümmü Taş und 1 weiteren Autor:innen. Die Arbeit nennt 21 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Severe COVID-19 is linked to cardiovascular complications from systemic inflammation and coagulation disorders. Addressing long-term COVID effects requires knowledge of its short-term cardiovascular impacts to enhance patient management and minimize adverse outcomes.

Objective

This study aimed to compare acute cardiac outcomes and function in severe versus non-severe COVID-19 patients, focusing on cardiovascular complications and prognostic implications. Material and Methods: A cross-sectional study from May to July 2021 at a tertiary care facility included 216 participants, split evenly into two groups of 108: severe and non-severe cases, matched by age and sex. The severe group required hospitalization or ICU care, while the non-severe group was treated outpatient. Evaluations included echocardiographic assessments, 12-lead electrocardiograms, and lab tests for cardiac biomarkers.

Results

Patients with severe conditions had an average age of 63.7 years, compared to 58.4 years for those with no severe conditions (p < 0.001). They also showed a higher prevalence of comorbidities such as diabetes (54.6% vs. 27.8%) and hypertension (39.8% vs. 25.0%, p < 0.05). Echocardiography indicated a reduced left ventricular ejection fraction (LVEF) of 42.5% versus 60.0% (p < 0.001) and an increased E/Em ratio of 14.5 compared to 10.0 (p < 0.001) among the groups. Right ventricular dimensions were larger, measuring 4.1 cm versus 3.0 cm (p < 0.001), with a higher myocardial performance index of 0.58 vs. 0.40 (p < 0.001). Severe cases had a mortality rate of 39.8% compared to 2.8% in no severe cases (p < 0.001).

Conclusion

Severe COVID-19 significantly impairs cardiac function, necessitating comprehensive cardiovascular evaluation and targeted interventions to improve outcomes

Zitieren

APA

Taş, Ü., & Taş, S. (2025). Acute Outcomes and Cardiac Functions in Severe COVID-19. Muş Alparslan Üniversitesi Sağlık Bilimleri Dergisi. https://doi.org/10.71255/maunsbd.1685179

Vancouver

Taş Ü, Taş S. Acute Outcomes and Cardiac Functions in Severe COVID-19. Muş Alparslan Üniversitesi Sağlık Bilimleri Dergisi. 2025. doi:10.71255/maunsbd.1685179

BibTeX
@article{Ta2025,
  author = {Taş, Ümmü and Taş, Sedat},
  title = {Acute Outcomes and Cardiac Functions in Severe COVID-19},
  journal = {Muş Alparslan Üniversitesi Sağlık Bilimleri Dergisi},
  year = {2025},
  doi = {10.71255/maunsbd.1685179}
}
Kostenlos starten →